what is the difference of tirzepatide and semaglutide Tirzepatide vs Semaglutide Semaglutide vs. Tirzepatide: Which GLP-1
Description
Real-world data link semaglutide, tirzepatide to improved heart failure outcomes Semaglutide and tirzepatide can help patients with heart failure with preserved ejection fraction (HFpEF) significantly improve their heart health, according to new data presented at ESC Congress 2025, the annual meeting of the European Society of Cardiology
Coadministration with other GLP-1 RAs should be avoided
Once that date passes, the medication may gradually lose potency, and sterility can no longer be fully guaranteed, especially after the vial has been punctured multiple times
The safety profile is favorable, with common side effects including mild to moderate gastrointestinal issues like nausea and diarrhea, and a low rate of discontinuation due to adverse events
The onset of allergic reactions can occur rapidly after injection, making it vital for patients to monitor themselves closely after each dose
